Evidentic GmbH

Clinical-grade molecules from licensed drugs can be difficult to obtain due to their complex production and regulatory requirements. As a pharmaceutical wholesaler, Evidentic specializes in repackaging therapeutic molecules, such as monoclonal antibodies (mAbs), antibody drug-conjugates (ADCs), fusion proteins, or bi-specifics, from licensed drugs into lab consumables for research and development projects. Evidentic provides these small units of licensed drugs, the so-called drug aliquots, and the corresponding analytical data, ensuring the quality of the molecules through documented transport, preparation, and storage conditions according to the chain of custody. 

Additionally, the company offers a portfolio of different batches of the same active pharmaceutical ingredient (API), licensed biosimilar drugs, and in-depth analytical data to streamline the drug development process. With Evidentic, researchers and pharmaceutical companies have access to high-quality reference standards, which transform time-consuming and costly sourcing procedures into a fast and easy way to procure clinical-grade molecules from licensed drugs from one supplier. The company prides itself on providing reliable high-quality products, unique batch collections, and excellent customer service with short response times, transparent pricing, and timelines.